Clinical outcomes and risk factors for severe COVID‐19 in patients with haematological disorders receiving chemo‐ or immunotherapy

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

(2020) Zunyou Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

Risk of COVID-19 for patients with cancer

(2020) Hanping Wang et al.   LANCET ONCOLOGY

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

(2020) Wenhua Liang et al.   LANCET ONCOLOGY

Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China

(2020) L. Zhang et al.   ANNALS OF ONCOLOGY

Clinical Outcome of Coronavirus Disease 2019 in Haemato‐oncology Patients

(2020) James A. Aries et al.   BRITISH JOURNAL OF HAEMATOLOGY

Survival study of hospitalised patients with concurrent COVID‐19 and haematological malignancies

(2020) Fernando Martín‐Moro et al.   BRITISH JOURNAL OF HAEMATOLOGY

Covid‐19 in Bone Marrow Transplant Recipients: Reflecting on a Single Centre Experience

(2020) Alexandros Kanellopoulos et al.   BRITISH JOURNAL OF HAEMATOLOGY

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

(2020) Julie Helms et al.   INTENSIVE CARE MEDICINE

Incidence of venous thromboembolism in hospitalized patients with COVID‐19

(2020) Saskia Middeldorp et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

ISTH interim guidance on recognition and management of coagulopathy in COVID‐19

(2020) Jecko Thachil et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia

(2020) Songping Cui et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study

(2020) Lennard Y W Lee et al.   LANCET

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

(2020) Nicole M Kuderer et al.   LANCET

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

(2020) Fei Zhou et al.   LANCET

COVID-19 in persons with haematological cancers

(2020) Wenjuan He et al.   LEUKEMIA

COVID-19 and Cancer: a Comprehensive Review

(2020) Rohit Gosain et al.   Current Oncology Reports

Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak

(2020) Mengyuan Dai et al.   Cancer Discovery

Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation

(2020) Eolia Brissot et al.   BONE MARROW TRANSPLANTATION

Haematological cancers and the risk of severe COVID‐19: Exploration and critical evaluation of the evidence to date

(2020) Dima El‐Sharkawi et al.   BRITISH JOURNAL OF HAEMATOLOGY

Poor outcome and prolonged persistence of SARS‐CoV‐2 RNA in COVID‐19 patients with haematological malignancies; King's College Hospital experience

(2020) Vallari Shah et al.   BRITISH JOURNAL OF HAEMATOLOGY

Regional outcomes of severe acute respiratory syndrome coronavirus 2 infection in hospitalised patients with haematological malignancy

(2020) Stephen Booth et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

(2020) F.A. Klok et al.   THROMBOSIS RESEARCH

Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML

(2019) Alexander E. Perl et al.   NEW ENGLAND JOURNAL OF MEDICINE

Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia

(2018) Courtney D. DiNardo et al.   BLOOD